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Abstract 
The lack of purine salvage enzyme, adenine phos-
phoribosyltransferase (APRT), leads to 2,8-dihydroxy-
adenine stone formation and/or crystalluria because it is 
insoluble in urine. Urolithiasis composed of 2,8-dihy-
droxyadenine is not only formed in a complete defect of 
APRT, but also in a partial deficiency of this enzyme. 
The defect is inherited as an autosomal recessive trait, 
the homozygous state is associated with high urinary 
levels of 2,8-dihydroxyadenine and with crystalluria, 
calculus formation, and potential nephrotoxicity. Deter-
mination of the APRT activity will facilitate quantifica-
tion of the enzyme deficiency and elucidation of the he-
reditary history. 2, 8-dihydroxyadenine excretion in the 
24-hour urine and its circadian rhythm were determined 
using a new method of high performance liquid chro-
matography determination. By means of a standard case 
presentation, we illustrate the analysis of urinary sedi-
ments and calculi as well as the scanning electron mi-
croscopic images of this kind of stone. 
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Introduction 
In 1968, Kelly et al. described a formerly un-
known disorder in purine metabolism caused by a defi-
ciency of the enzyme adenine phosphoribosyltransferase 
(APRT) [8]. This defect is inherited as an autosomal 
recessive trait [l, 7). 
The complete or partial lack of the salvage en-
zyme obstructs the conversion of adenine to adenosine 
monophosphate. The alternative metabolic route availa-
ble for urinary excretion is the oxydation of the in-
creased concentration of adenine to 8-hydroxyadenine 
(Fig. 1). The inadequate solubility of 2,8-dihydroxy-
adenine (2,8-DHA) in the normal pH-range of human 
urine (namely 4.8-8.0) leads to crystalluria and stone 
formation [ 12]. Homozygotes tend to develop urinary 
calculi in early childhood. As stone formation in chil-
dren does not occur frequently, the possibility of 2,8-
DHA stones should come to mind when X-ray negative 
stones are found in children [I, 6, 7, 13). 2,8-DHA 
urolithiasis in homozygotes was first described in 1974 
[2]. Since that time, 20 cases have been described in 
medical literature [9]. By means of a standard case 
presentation, we illustrate here the analysis of 2,8-DHA 
urinary sediments and calculi as well as the scanning 
electron microscopic (SEM) appearance of this kind of 
stone [11]. 
Materials and Methods 
A 30-year-old male patient, who had produced X-
ray negative calculi in his left kidney since infancy, lost 
the kidney at 8 years of age (no stone analysis). At the 
age of 22, first spontaneous excretion of stones from the 
remaining right kidney was observed. The first stone 
analysis by infrared (IR) spectroscopy was made after a 
further 3 years and showed 2,8-DHA. In 1987, 8 con-
crements in the right kidney were sonographically de-
tected. The majority of the stones were removed percu-
taneously. The remaining concrements were passed 
spontaneously. The stone analysis by IR spectroscopy 
revealed also 2,8-DHA. There was no known family 
history of lithiasis. 
Laboratory Investigations 
Urinary sediment: Microscopic examination of 
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Figure 1. Diagram of purine metabolism. XO = xan-
thine oxidase, APRT = adenine phosphoribosyltrans-
ferase, HGPRT = Hypoxanthineguaninephosphoribosyl-




Figure 2. Microscopic examination of the crystalline 
urinary sediment containing 2,8-dihydroxyadeninuria 
spherical crystals in a radial corona. Bar = ??? µm. 
Figure 3. Scanning electron micrograph of 2,8-dihy-




Figure 4. Infrared spectra of a 2,8-DHA (a) and uric 
acid (b). At wavelengths 3045, 3238 and 3338 cm-1, 
there are characteristic absorptions which do not occur 
in uric acid. 
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Figure 5. 2,8-DHA concentration in urine with (solid 
line) and without 3 x 100 mg allopurinol treatment 
(dotted line). 
the crystalline urinary sediment was made after centrifu-
gation. A large quantity of crystalline material was ob-
tained for quantitative IR analysis. IR spectroscopic 
concrement analysis of the urinary sediment and the 
stone was performed using the KBr press process [14]. 
APRT activity: The activity of the enzyme was 
assayed in the erythrocyte hemolysat by a radiochemical 
technique [3]. Quantitative 2,8-DHA determination in 
the urine was performed using high performance liquid 
chromatography (HPLC) in conj unction with a separat-
ing system specially developed for purine [4]. 
SEM investigations: In order to study the mor-
phology of the concrements, their surfaces, stone inter-
spaces, fracture surfaces, and a commercially available 
synthetic test substance of 2,8-DHA were examined by 
scanning electron microscopy (SEM). 
2,8-Dihydroxyadenine crystals and stones 
Results 
In the presence of APRT deficiency, and depend-
ent upon the scale of the enzyme deficiency, crystals 
were detected in the urine. Masses of crystals were al-
ways present; they were spherical in shape and brown-
red in color. Under a light microscope, the crystalline 
arrangement was spherolitic (Figure 2). Under the 
SEM, nests of individual crystals were detected, some 
10 µm in diameter, which also aggregated to form 
microliths (Figure 3). 
2,8-DHA can only be detected using modern 
chemophysical methods of analysis [5, I 0]. The chemi-
cal method will always produce a false result indicating 
uric acid. Infra-red spectroscopic analysis indicated 
that both urinary sediments and stones consisted of pure 
2, 8-dihydroxyadenine. The characteristic absorptions 
observed at wavelengths 3045, 3238 and 3338 cm- 1 do 
not occur in any other type of urolith, e.g., uric acid 
(Figures 4a, 4b). 
In order to obtain a clear picture of the extent of 
the enzyme deficiency, the lack of APRT activity in 
haemolysed erythrocytes must be determined. Caution 
is advisable if the patient has just received blood trans-
fusions, which can lead to a temporary increase in 
APRT activity. 
The determination of 2,8-DHA in urine was car-
ried out by the HPLC method. In the 24-hour urines of 
healthy test persons, no "-,8-DHA could be traced. If 
2,8-DHA is found, it can always be regarded as an indi-
cator of APRT deficiency. 
2,8-DHA excretion rates in our patient ranged be-
tween 125 and 160 µmol/1 (i.e., 245-414 µmol per 24 
hours). Treatment with 300 mg allopurinol per day re-
duced the daily excretion to 40 µmol/day. The excre-
tion of 2,8-DHA shows a characteristic day/night 
rhythm. Increased rates were registered at night and in 
the morning hours. The administration of the xanthino-
xydase inhibitor allopurinol reduced excretion rates to a 
constantly low level, while adenine concentration in 
urine increased (Figure 5). 
SEM examination of the synthetic test material 
after fast recrystallization revealed plaque-shaped 
structures (Figure 6), and after slow recrystallization 
spherical, matted structures (Figure 7). 
With increasing magnification, the 2,8-DHA 
stone shows a spherical surface, a felt-like surface and 
spherolite surface with matted needle-shaped crystals 
(Figures 8, 9, 10 and 11). The SEM examination of 
structures in stone interspaces revealed mostly needle-
shaped crystals (Figure 12), although, sometimes lance-
shaped crystals were also observed (Figure 13). After 
fragmentation of a 2,8-DHA stone and SEM examination 
of individual fragments, microliths with an irregular 
surface, and sometimes a fracture surface with peripher-




Only the introduction of new methods of urinary 
stone analysis such as X-ray diffraction and IR spectros-
copy have made it possible to identify 2,8-DHA calculi. 
There is no structural difference between 2,8-DHA and 
uric acid. Since there is still no way to heal this "in-
born error of metabolism", recurrence of stone forma-
tion can only be prevented by strict life-long treatment. 
The SEM has been instrumental in yielding valua-
ble new data in the field of stone research. The variety 
of microscopic forms and the different structures of 
urine stones can be observed in details with the SEM. 
Whereas examinations have been carried out with the 
SEM on most types of urinary stones, an analysis of the 
2,8-DHA stone, due to its extreme rarity, was lacking. 
This paper presents SEM analysis of the test substance 
after recrystallization, urinary sediment, stone surface, 
stone interfaces, and fracture surface of the 2,8-DHA 
stone. Once a 2,8-DHA stone has been diagnosed, the 
enzyme deficiency can be determined by measuring 
APRT activity in erythrocyte haemolysate. Making use 
of this relatively simple test, a possible hereditary factor 
may be determined in other family members. 
The HPLC method permits a quantitative determi-
nation of 2,8-DHA excretion in urine. With this meth-
od, the monitoring of treatment is easy and reliable. In 
addition to allopurinol therapy, the dilution of urine 
throughout the day, sufficient fluid intake, and a low-
purine diet are advised to eliminate 2,8-DHA excretion 
in urine. 
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Figure 6. Synthetic test material. Plaque-shaped structure. Fast crystallisation. Bar = 10 µm. 
Figure 7. Synthetic test material. Spherical, matted structure. Slow crystallisation. Bar = 10 µm. 
Figure 8. Spherical surface. Bar = 100 µm. 
Figure 9. Spherical, now felt-like surface. Bar = 100 µm. 
Figure 10. Spherolite surface with matted needle-shaped crystals. Bar 
Figure 11. Similar structures with regular crystals. Bar = 10 µm. 
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10 µm. 
2,8-Dihydroxyadenine crystals and stones 
Figure 12. Needle-shaped crystals. Bar = 10 µm. 
Figure 13. Lance-shaped crystals. Bar = 10 µm. 
Figure 14. Microlith with irregular surface. Bar = 10 µm. 
Figure 15. Doubled magnification shows a similar surface structure. Bar = 10 µm. 
Figure 16. Fracture surface of a 2,8-DHA stone. Bar = 10 µm. 
Figure 17. Fracture surface with peripheral regular crystals. Bar = 10 µm. 
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Discussion with Reviewers 
H. Iwata: Was dissolution carried out by heating or 
changing pH? Was the substance dissolved in pure 
water, buffer solution, and urine? 
Authors: 2,8-DHA was obtained from Sigma (Article 
no. D7382). The substance was heated in pure water at 
neutral pH at 80°C. After filtration, one part was 
cooled down to room temperature (slow crystallization), 
and the other part in ice water (fast crystallization). 
D.B. Leusmann: Is there a possibility to resolve 2,8-
DHA stones either by oral medication (similar to uric 
acid stones) or by direct dissolution after pyelostomy 
and/or indwelling ureteral stents? 
Authors: The dissolution of 2,8-DHA stones by oral 
medication is not possible. Solubility of 2,8-DHA 
stones in the pH-range of 4.8-8.0 varies between 3 and 
5 mg/I. A considerable increase in solubility can be 
achieved at a pH-range less than 2 or more than 9. 5; 
however, such extensive changes in human pH-values 
1080 
cannot be achieved through oral medication. In any 
case, attempts to change the pH-value by means of per-
cutaneous chemolitholysis will fail because of incompat-
ible tissue tolerance; even if this problem was irrele-
vant, the many potential side effects of this kind of 
therapy would forbid its application. 
S.R. Khan: What are the some of the other features 
associated with this disease? 
Authors: Other features associated with APRT-defi-
ciency on its own are not known. APRT-deficiency, 
when not treated, may lead to nephrocalcinosis with 
resultant renal failure. 
A. Rogers: In the Materials and Methods section, you 
mention that the first stone analysis showed 2,8-DHA. 
What technique was used for this analysis? 
Authors: We used infrared spectroscopy. 
A. Rogers: Do you think that the brown red colour of 
the 2,8-DHA crystals is due to blood stains? Uric acid 
microliths are often red orange. Were the 2,8-DHA 
crystals similar in colour to uric acid crystals? 
Authors: 2,8-DHA crystals of brown-red colour ap-
peared in several patients and cannot be attributed to 
blood stains in our opinion. It is most likely that urine 
colouring matter may be adsorbed by 2,8-DHA, which 
causes this kind of stone to appear very similar to a uric 
acid stone. 
A. Rogers: Figures 11, 12 and 13 show crystals which 
are very similar to the morphological features of sodium 
urate. Were no other stone components besides 2,8-
DHA detected (e.g., uric acid and salts thereof)? 
Authors: Analyses by IR proved 2,8-DHA stones to be 
extremely pure. Components of uric acid or salts 
thereof are rather unlikely. 
A. Rogers: How sensitive are your IR measurements? 
Authors: The sensitivity of IR spectroscopic measure-
ments is dependent on the composition of substances in-
vestigated. All components exceeding 5 % can be un-
mistakably determined. 
A. Rogers: Did you consider verifying your results by 
subjecting the crystals to another analytical technique 
such as as X-ray powder diffraction or mass spec-
trometry? 
Authors: Results achieved through IR spectroscopy 
were confirmed by X-ray diffraction. Mass 
spectroscopy was not applied. 
Editor: Am I correct in understanding that Figures 8 to 
17 are from different stones collected from your 30 year 
old patient? 
Authors: Yes; Figures 6 and 7 are scanning electron 
micrographs from synthetic crystals; while Figures 8 to 
17 are from stones collected from the patient. 
